Medial temporal lobe atrophy is underreported and may have important clinical correlates in medical inpatients

BMC Geriatrics

Elisabet Londos¹  Lennart Minthon¹  Lars Stavenow²  Danielle van Westen³  Gustav Torisson¹ 

[1] Department of Clinical Sciences, Clinical Memory Research Unit, Lund University, Lund, Sweden;Department of Internal Medicine, Skåne University Hospital, Malmö, Sweden;Center for Medical Imaging and Physiology, Skåne University Hospital, Lund, Sweden

关键词: Inpatients;    Computerised tomography;    Neurodegenerative diseases;    Dementia;   

Others  :  1218305
DOI  :  10.1186/s12877-015-0066-4

 received in 2015-01-20, accepted in 2015-05-29,  发布年份 2015

【 摘 要 】

Background

The diagnostic workup in dementia includes brain imaging with reading focussed on signs of cerebrovascular and neurodegenerative disease. We hypothesised that these findings may be underreported in hospital patients, where imaging is often performed to rule out obvious pathology such as haemorrhage. In this study, we review cranial computed tomography (CT) in medical inpatients for white matter changes and atrophy. Our aim was to determine the clinical relevance of such findings and to what extent they were underreported.

Methods

Records from 200 inpatients aged over 60 years, who had been subjected to MMSE (mini-mental state examination) and CDT (clock-drawing test), were reviewed for cranial CT. Transverse and coronal slices were reassessed using visual rating scales regarding white matter changes (WMC), global cortical atrophy (GCA) and medial temporal lobe atrophy (MTA). Findings were compared with the original radiology reports and cognitive test results.

Results

Cranial CT had been performed in 94 of 200(47 %) patients. Of these, 58(62 %) had abnormal WMC, 35(37 %) abnormal GCA and 34(36 %) abnormal MTA. All three findings had associations with cognitive test results. Abnormal MTA was associated with lower results on the overall score on MMSE and on orientation, memory and language items. All three measurements were underreported in the original radiology reports; none of the 34 patients with abnormal MTA had been reported originally.

Conclusions

Signs of neurodegenerative disease, especially MTA, were highly underreported in cranial CT scans performed in medical inpatients. At the same time, MTA seemed to hold the most important clinical correlates. Our results suggest that MTA should be reported more regularly in this setting.

【 授权许可】

   
2015 Torisson et al.

【 图 表 】

Fig. 1.

Fig. 2.

Fig. 3.

【 参考文献 】

• [1]Connolly A, Gaehl E, Martin H, Morris J, Purandare N: Underdiagnosis of dementia in primary care: variations in the observed prevalence and comparisons to the expected prevalence. Aging Ment Health 2011, 15(8):978-984.
• [2]Lopponen M, Raiha I, Isoaho R, Vahlberg T, Kivela SL: Diagnosing cognitive impairment and dementia in primary health care – a more active approach is needed. Age Ageing 2003, 32(6):606-612.
• [3]Brayne C, Gao L, Dewey M, Matthews FE: Dementia before death in ageing societies–the promise of prevention and the reality. PLoS Med 2006., 3(10) Article ID e397
• [4]Thies W, Bleiler L: 2013 Alzheimer's disease facts and figures. Alzheimer's Dement 2013, 9(2):208-245.
• [5]Bynum JP, Rabins PV, Weller W, Niefeld M, Anderson GF, Wu AW: The relationship between a dementia diagnosis, chronic illness, medicare expenditures, and hospital use. J Am Geriatr Soc 2004, 52(2):187-194.
• [6]Natalwala A, Potluri R, Uppal H, Heun R: Reasons for hospital admissions in dementia patients in Birmingham, UK, during 2002–2007. Dement Geriatr Cogn Disord 2008, 26(6):499-505.
• [7]Rudolph JL, Zanin NM, Jones RN, Marcantonio ER, Fong TG, Yang FM, Yap L, Inouye SK: Hospitalization in community-dwelling persons with Alzheimer's disease: frequency and causes. J Am Geriatr Soc 2010, 58(8):1542-1548.
• [8]Department of Health, United Kingdom. Prime Minister's challenge on dementia 2020. London 2015. https://www.gov.uk/government/publications/prime-ministers-challenge-on-dementia-2020. Accessed 22 Apr 2015.
• [9]Socialstyrelsen: Nationell utvärdering – Vård och omsorg vid demenssjukdom 2014 – Indikatorer och underlag för bedömningar In 2014-2-1. Socialstyrelsen, Stockholm; 2014:147.
• [10]Feldman HH, Jacova C, Robillard A, Garcia A, Chow T, Borrie M, Schipper HM, Blair M, Kertesz A, Chertkow H: Diagnosis and treatment of dementia: 2. Diagnosis. CMAJ 2008, 178(7):825-836.
• [11]Holzer S, Warner JP, Iliffe S: Diagnosis and management of the patient with suspected dementia in primary care. Drugs Aging 2013, 30(9):667-676.
• [12]Sorbi S, Hort J, Erkinjuntti T, Fladby T, Gainotti G, Gurvit H, Nacmias B, Pasquier F, Popescu BO, Rektorova I, et al.: EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia. Eur J Neurol 2012, 19(9):1159-1179.
• [13]Waldemar G, Dubois B, Emre M, Georges J, McKeith IG, Rossor M, Scheltens P, Tariska P, Winblad B: Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. Eur J Neurol 2007, 14(1):e1-26.
• [14]Scheltens P, Fox N, Barkhof F, De Carli C: Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion. Lancet Neurol 2002, 1(1):13-21.
• [15]Jack CR Jr, Barkhof F, Bernstein MA, Cantillon M, Cole PE, Decarli C, Dubois B, Duchesne S, Fox NC, Frisoni GB, et al.: Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease. Alzheimer's Dement 2011, 7(4):474-485.
• [16]McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, et al.: The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's Dement 2011, 7(3):263-269.
• [17]Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, et al.: Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993, 43(2):250-260.
• [18]Hirano LA, Bogardus ST Jr, Saluja S, Leo-Summers L, Inouye SK: Clinical yield of computed tomography brain scans in older general medical patients. J Am Geriatr Soc 2006, 54(4):587-592.
• [19]Soiza RL, Sharma V, Ferguson K, Shenkin SD, Seymour DG, Maclullich AM: Neuroimaging studies of delirium: a systematic review. J Psychosom Res 2008, 65(3):239-248.
• [20]Torisson G, Minthon L, Stavenow L, Londos E: Cognitive impairment is undetected in medical inpatients: a study of mortality and recognition amongst healthcare professionals. BMC Geriatr 2012, 12:47. BioMed Central Full Text
• [21]Torisson G, Minthon L, Stavenow L, Londos E: Multidisciplinary intervention reducing readmissions in medical inpatients: a prospective, non-randomized study. Clin Interv Aging 2013, 8:1295-1304.
• [22]Folstein MF, Folstein SE, McHugh PR: ”Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatric Res 1975, 12(3):189-198.
• [23]Jefferson AL, Cosentino SA, Ball SK, Bogdanoff B, Leopold N, Kaplan E, Libon DJ: Errors produced on the mini-mental state examination and neuropsychological test performance in Alzheimer's disease, ischemic vascular dementia, and Parkinson's disease. J Neuropsychiatry Clin Neurosci 2002, 14(3):311-320.
• [24]Shulman KI: Clock-drawing: is it the ideal cognitive screening test? Int J Geriatr Psychiatry 2000, 15(6):548-561.
• [25]Charlson M, Szatrowski TP, Peterson J, Gold J: Validation of a combined comorbidity index. J Clin Epidemiol 1994, 47(11):1245-1251.
• [26]Wattjes MP, Henneman WJ, van der Flier WM, de Vries O, Traber F, Geurts JJ, Scheltens P, Vrenken H, Barkhof F: Diagnostic imaging of patients in a memory clinic: comparison of MR imaging and 64-detector row CT. Radiology 2009, 253(1):174-183.
• [27]Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA: MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. Am J Roentgenol 1987, 149(2):351-356.
• [28]Kapeller P, Barber R, Vermeulen RJ, Ader H, Scheltens P, Freidl W, Almkvist O, Moretti M, del Ser T, Vaghfeldt P, et al.: Visual rating of age-related white matter changes on magnetic resonance imaging: scale comparison, interrater agreement, and correlations with quantitative measurements. Stroke 2003, 34(2):441-445.
• [29]Fazekas F, Niederkorn K, Schmidt R, Offenbacher H, Horner S, Bertha G, Lechner H: White matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors. Stroke 1988, 19(10):1285-1288.
• [30]Schmidt R, Hayn M, Fazekas F, Kapeller P, Esterbauer H: Magnetic resonance imaging white matter hyperintensities in clinically normal elderly individuals. Correlations with plasma concentrations of naturally occurring antioxidants. Stroke 1996, 27(11):2043-2047.
• [31]Pasquier F, Leys D, Weerts JG, Mounier-Vehier F, Barkhof F, Scheltens P: Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts. Eur Neurol 1996, 36(5):268-272.
• [32]Scheltens P, Pasquier F, Weerts JG, Barkhof F, Leys D: Qualitative assessment of cerebral atrophy on MRI: inter- and intra-observer reproducibility in dementia and normal aging. Eur Neurol 1997, 37(2):95-99.
• [33]Fazekas F, Alavi A, Chawluk JB, Zimmerman RA, Hackney D, Bilaniuk L, Rosen M, Alves WM, Hurtig HI, Jamieson DG, et al.: Comparison of CT, MR, and PET in Alzheimer's dementia and normal aging. J Nucl Med 1989, 30(10):1607-1615.
• [34]Barber R, Gholkar A, Scheltens P, Ballard C, McKeith IG, O'Brien JT: Medial temporal lobe atrophy on MRI in dementia with Lewy bodies. Neurology 1999, 52(6):1153-1158.
• [35]Visser PJ, Verhey FR, Hofman PA, Scheltens P, Jolles J: Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment. J Neurol Neurosurg Psychiatry 2002, 72(4):491-497.
• [36]Korf ES, Wahlund LO, Visser PJ, Scheltens P: Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment. Neurology 2004, 63(1):94-100.
• [37]Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, Kuiper M, Steinling M, Wolters EC, Valk J: Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1992, 55(10):967-972.
• [38]Koedam EL, Lehmann M, van der Flier WM, Scheltens P, Pijnenburg YA, Fox N, Barkhof F, Wattjes MP: Visual assessment of posterior atrophy development of a MRI rating scale. Eur Radiol 2011, 21(12):2618-2625.
• [39]Cavallin L, Bronge L, Zhang Y, Oksengard AR, Wahlund LO, Fratiglioni L, Axelsson R: Comparison between visual assessment of MTA and hippocampal volumes in an elderly, non-demented population. Acta Radiol 2012, 53(5):573-579.
• [40]Lehmann M, Koedam EL, Barnes J, Bartlett JW, Ryan NS, Pijnenburg YA, Barkhof F, Wattjes MP, Scheltens P, Fox NC: Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease. Neurobiol Aging 2012, 33(3):627.
• [41]Scheltens P, van de Pol L: Impact commentaries. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 2012, 83(11):1038-1040.
• [42]Pereira JB, Cavallin L, Spulber G, Aguilar C, Mecocci P, Vellas B, Tsolaki M, Kloszewska I, Soininen H, Spenger C et al. Influence of age, disease onset and ApoE4 on visual medial temporal lobe atrophy cut-offs. J Int Med. 2013;275(3):317-30.
• [43]Tung C, Lindgren A, Siemund R, van Westen D. Emergency room decision-making for urgent cranial computed tomography: selection criteria for subsets of non-trauma patients. Acta Radiol. 2013.
• [44]Overdorp EJ, Kessels RP, Claassen JA, Oosterman JM: Cognitive impairments associated with medial temporal atrophy and white matter hyperintensities: an MRI study in memory clinic patients. Frontiers in aging neuroscience 2014, 6:98.